Ruchi N Patel1, Valeria G Esparza2, Jin-Shei Lai1, Elizabeth L Gray1, Bryce B Reeve3, Rowland W Chang1, David Cella1, Kaveh Ardalan4. 1. Northwestern University Feinberg School of Medicine, Chicago, Illinois. 2. University of Illinois-Chicago College of Medicine, Chicago. 3. Duke University School of Medicine, Durham, North Carolina. 4. Duke University School of Medicine, Durham, North Carolina, and Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Abstract
OBJECTIVE: Patient-Reported Outcomes Measurement Information System (PROMIS) measures can be administered via computerized adaptive testing (CAT) or fixed short forms (FSFs), but the empirical benefits of CAT versus FSFs are unknown in juvenile myositis (JM). The present study was undertaken to assess whether PROMIS CAT is feasible, precise, correlated with FSFs, and less prone to respondent burden and floor/ceiling effects than FSFs in JM. METHODS: Patients 8-17 years of age (self-report and parent proxy) and parents of patients 5-7 years of age (only parent proxy) completed PROMIS fatigue, pain interference, upper extremity function, mobility, anxiety, and depressive symptoms measures. Pearson correlations, paired t-tests, and Cohen's d were calculated between PROMIS CAT and FSFs. McNemar's test assessed floor/ceiling effects between CAT and FSFs. Precision and respondent burden were examined across the T score range. RESULTS: Data from 67 patient-parent dyads were analyzed. CAT and FSF mean scores did not significantly differ except in parent proxy anxiety and fatigue (effect size 0.23 and 0.19, respectively). CAT had less pronounced floor/ceiling effects at the less symptomatic extreme in all domains except self-report anxiety. Increased item burden and higher SEs were seen in less symptomatic scorers for CAT. Modified stopping rules limiting CAT item administration did not decrease precision. CONCLUSION: PROMIS CAT appears to be feasible and correlated with FSFs. CAT had less pronounced floor/ceiling effects, allowing detection of individual differences in less symptomatic patients. Modified stopping rules for CAT may decrease respondent burden. CAT can be considered for long-term follow-up of JM patients.
OBJECTIVE: Patient-Reported Outcomes Measurement Information System (PROMIS) measures can be administered via computerized adaptive testing (CAT) or fixed short forms (FSFs), but the empirical benefits of CAT versus FSFs are unknown in juvenile myositis (JM). The present study was undertaken to assess whether PROMIS CAT is feasible, precise, correlated with FSFs, and less prone to respondent burden and floor/ceiling effects than FSFs in JM. METHODS: Patients 8-17 years of age (self-report and parent proxy) and parents of patients 5-7 years of age (only parent proxy) completed PROMIS fatigue, pain interference, upper extremity function, mobility, anxiety, and depressive symptoms measures. Pearson correlations, paired t-tests, and Cohen's d were calculated between PROMIS CAT and FSFs. McNemar's test assessed floor/ceiling effects between CAT and FSFs. Precision and respondent burden were examined across the T score range. RESULTS: Data from 67 patient-parent dyads were analyzed. CAT and FSF mean scores did not significantly differ except in parent proxy anxiety and fatigue (effect size 0.23 and 0.19, respectively). CAT had less pronounced floor/ceiling effects at the less symptomatic extreme in all domains except self-report anxiety. Increased item burden and higher SEs were seen in less symptomatic scorers for CAT. Modified stopping rules limiting CAT item administration did not decrease precision. CONCLUSION: PROMIS CAT appears to be feasible and correlated with FSFs. CAT had less pronounced floor/ceiling effects, allowing detection of individual differences in less symptomatic patients. Modified stopping rules for CAT may decrease respondent burden. CAT can be considered for long-term follow-up of JM patients.
Authors: A M Huber; J E Hicks; P A Lachenbruch; M D Perez; L S Zemel; R M Rennebohm; C A Wallace; C B Lindsley; M H Passo; S H Ballinger; S L Bowyer; A M Reed; P H White; I M Katona; F W Miller; L G Rider; B M Feldman Journal: J Rheumatol Date: 2001-05 Impact factor: 4.666
Authors: Debra E Irwin; Brian D Stucky; David Thissen; Esi Morgan Dewitt; Jin Shei Lai; Karin Yeatts; James W Varni; Darren A DeWalt Journal: Qual Life Res Date: 2010-03-05 Impact factor: 4.147
Authors: Angela Byun Robinson; Mark F Hoeltzel; Dawn M Wahezi; Mara L Becker; Elizabeth A Kessler; Heinrike Schmeling; Ruy Carrasco; Adam M Huber; Brian M Feldman; Ann M Reed Journal: Arthritis Care Res (Hoboken) Date: 2014-03 Impact factor: 4.794
Authors: James W Varni; Brooke Magnus; Brian D Stucky; Yang Liu; Hally Quinn; David Thissen; Heather E Gross; I-Chan Huang; Darren A DeWalt Journal: Qual Life Res Date: 2013-10-02 Impact factor: 4.147
Authors: Dinesh Khanna; Eswar Krishnan; Esi Morgan Dewitt; Puja P Khanna; Brennan Spiegel; Ron D Hays Journal: Arthritis Care Res (Hoboken) Date: 2011-11 Impact factor: 4.794
Authors: Heather O Tory; Ruy Carrasco; Thomas Griffin; Adam M Huber; Philip Kahn; Angela Byun Robinson; David Zurakowski; Susan Kim Journal: Pediatr Rheumatol Online J Date: 2018-04-19 Impact factor: 3.054
Authors: T Petra Rausch-Koster; Michiel A J Luijten; F D Verbraak; Ger H M B van Rens; Ruth M A van Nispen Journal: Transl Vis Sci Technol Date: 2022-04-01 Impact factor: 3.283